D. Argenti

发表

THE PHARMACOKINETICS AND PHARMACODYNAMICS OF DESMOPRESSIN: EFFECT ON PLASMA FACTOR VIII C AND VON WILLEBRAND FACTOR

D. Argenti, B. Jensen, D. Heald, 1997, American journal of therapeutics.

Pharmacokinetics and pharmacodynamics of canagliflozin in pediatric patients with type 2 diabetes

W. Tamborlane, D. Argenti, D. Polidori, 2018, Pediatric diabetes.

Measurement of low picomolar levels of triamcinolone acetonide in human bronchoalveolar lavage fluid by gas chromatography-electron-capture negative-ion mass spectrometry.

W. Hubbard, R. Schleimer, D. Argenti, 2001, Analytical biochemistry.

COMPARATIVE PHARMACOKINETICS AND BIOAVAILABILITY OF DILACOR XR AND CARDIZEM CD IN HEALTHY VOLUNTEERS

D. Argenti, D. Heald, J. Ziemniak, 1995, American journal of therapeutics.

A Pharmacokinetic Study to Evaluate the Absolute Bioavailability of Triamcinolone Acetonide following Inhalation Administration

D. Argenti, D. Heald, B. Shah, 1999, Journal of clinical pharmacology.

Nasal Mucosal Inflammation Has No Effect on the Absorption of Intranasal Triamcinolone Acetonide

D. Argenti, D. Heald, J. Ziemniak, 1994, Journal of clinical pharmacology.

Pharmacokinetics and Electrocardiographic Effect of Ebastine in Young Versus Elderly Healthy Subjects

D. Argenti, D. Heald, J. García, 1998, American journal of therapeutics.

Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence

Francis X. Muller, Amitava Mitra, Jack A. Cook, 2012, AAPS Journal.

A Mass Balance Study to Evaluate the Biotransformation and Excretion of [14C]‐Triamcinolone Acetonide following Oral Administration

R. Schleimer, D. Argenti, B. Jensen, 2000, Journal of clinical pharmacology.

A pharmacokinetic and pharmacodynamic comparison of desmopressin administered as whole, chewed and crushed tablets, and as an oral solution.

D. Argenti, D. Heald, D. Ireland, 2001, The Journal of urology.

Pharmacokinetics of Enoxaparin in Patients Undergoing Percutaneous Coronary Intervention With and Without Glycoprotein IIb/IIIa Therapy

D. Argenti, B. Jensen, D. Heald, 2003, American journal of therapeutics.

Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials

G. Raskob, E. Barnathan, C. Lipardi, 2020, Thrombosis and Haemostasis.

Design of a desipramine dosing regimen for the rapid induction and maintenance of maximal cortical β-adrenoceptor downregulation

D. Argenti, A. D'mello, 1994, Neuropharmacology.

A Study Comparing the Clinical Pharmacokinetics, Pharmacodynamics, and Tolerability of Triamcinolone Acetonide HFA‐134a Metered‐Dose Inhaler and Budesonide Dry‐Powder Inhaler following Inhalation Administration

D. Argenti, D. Heald, B. Shah, 2000, Journal of clinical pharmacology.